- Contributed to the upstream process development of CHO bioprocesses from project conception to release in manufacturing, spanning pre-clinical to late phase production. Consistently produced exceptional results by enhancing process performance, overcoming complex constraints to drive project milestones, and delivering comprehensive technical reports.- Proficiently navigated bioreactor control modalities (ReadyToProcess Wave 25, BioStat B-DCU, Xcellerex XDR, HyPerforma DynaDrive) and provided technical support for cGMP operations.- Spearheaded a '5S' lab optimization initiative to transform upstream and downstream laboratory spaces. The implementation established optimized workstations, created 'show-ready' environments, and instituted systems to ease maintenance.- Introduced a shutdown protocol for the BioProfile FLEX2 resulting in cost savings of up to $150,000 per year- Proactively coordinated cross-functional events with external stakeholders to promote the exchange of innovative technologies, drive business growth, and enhance engagement among diverse organizational teams.

- Executed all cGMP functions involved in the scale-up, production, and harvest of hybridoma cell culture systems.- Executed quality control measures such as nephelometry, mycoplasma detection, and isotype verification.- Contributed to laboratory upkeep and managed the inventory of reagents and consumables.

- Facilitated the seamless flow of over 1000 clinical specimens daily, managing accessioning, tissue processing, and staining.- Managed the inventory of chemical reagents and consumables and pioneered a Kanban system to streamline purchasing logistics. This resulted in a reduction of waste and hence an expense reduction of $100,000 YoY.- Performed manual tissue processing, microtomy, and staining to support operations as needed.